US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by Johnson & Johnson

< Previous 1 2 3 4 5 Next >
News headline image
Johnson & Johnson to Acquire V-Wave
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Participate in the 2024 Wells Fargo Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson reports Q2 2024 results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Completes Acquisition of Proteologix, Inc.
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Completes Acquisition of Shockwave Medical
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Acquire Shockwave Medical
From Johnson & Johnson
Via Business Wire
Tickers JNJ SWAV
News headline image
Johnson & Johnson Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Expands Commitment to Advance Health Equity
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Participate in the BofA Securities Health Care Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Completes Acquisition of Ambrx
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Participate in the Leerink Global Biopharma Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Participate in the Raymond James 45th Annual Institutional Investors Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Reports Q4 and Full-Year 2023 Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
< Previous 1 2 3 4 5 Next >